How Common Is Meningitis in Kids and Who’s at Risk?

Childhood meningitis has become far less common over the past three decades, but it still strikes roughly 1.3 million children worldwide each year, and the youngest babies face the steepest danger. Global incidence among children under 15 dropped by about 60% between 1990 and 2021, driven largely by vaccines against the bacteria most likely to cause severe disease.¹ That progress is real, but the disease remains disproportionately concentrated among newborns, children in low-income settings, and kids with certain medical or environmental vulnerabilities that many parents have never heard of.

The Numbers at a Glance

In 2021, the global incidence rate of meningitis in children aged 0 to 14 was about 66 per 100,000, down from roughly 165 per 100,000 in 1990.¹ That averages out to about 1.33 million new cases a year among children, with the mortality rate sitting around 5.6 per 100,000. But global averages hide enormous regional variation. Parts of sub-Saharan Africa still see incidence rates three to four times the world average. Western Sub-Saharan Africa recorded roughly 220 cases per 100,000 children in 2021, and Eastern and Central Sub-Saharan Africa were not far behind.¹ Countries with low socioeconomic development bear the heaviest burden overall.²

In high-income countries like those in Western Europe and North America, rates are dramatically lower, often well under 2 per 100,000 for bacterial meningitis specifically. A Dutch surveillance study spanning three decades found that bacterial meningitis incidence fell from about 6.4 to 1.6 per 100,000 between the early 1990s and late 2010s, with the sharpest drops among school-aged children.³ So for a parent in the United States or Europe, bacterial meningitis in a child is genuinely rare. But “rare” still means it happens, and when it does, the consequences can be severe.

Why Babies Under Three Months Are in a Category of Their Own

The single biggest risk factor for meningitis is simply being very young. Neonates and infants under six months face incidence rates that dwarf those of older children. For babies in their first five months of life, the rate was estimated at roughly 1,185 per 100,000 in 2021, with a mortality rate of about 541 per 100,000.² That is roughly 18 times the overall childhood rate. A newborn’s immune system is immature, and the antibodies passed from the mother during pregnancy only provide partial and temporary protection.

The germs that cause neonatal meningitis also differ from those that affect older children. Group B Streptococcus, a bacterium that commonly colonizes a mother’s gastrointestinal and genital tracts, remains the most frequent bacterial cause of meningitis in infants under 90 days old.⁴ The baby can pick up the bacterium during delivery. The leading causes of death in neonatal meningitis globally reflect this: Group B Streptococcus accounts for roughly 23% of neonatal meningitis deaths, followed by Klebsiella pneumoniae at about 17% and viral causes at around 15%.¹

What makes this age group especially dangerous is that the classic signs adults associate with meningitis — stiff neck, high fever, sensitivity to light — often do not appear. A UK and Ireland study of infants under 90 days found that the presentation was frequently nonspecific, and only about half of cases even had a fever at the time of diagnosis.⁵ Parents may see only fussiness, poor feeding, or unusual sleepiness, symptoms that overlap with a dozen benign conditions. This vagueness is a major reason meningitis in young babies gets missed or diagnosed late.

Bacterial Versus Viral Meningitis

Not all meningitis is the same, and the distinction between bacterial and viral forms matters enormously for a child’s prognosis. Viral meningitis is much more common and almost always less dangerous. In a study of over 500 children with aseptic (non-bacterial) meningitis, there were no fatalities, no serious complications, and no lasting damage among hospitalized patients.⁶ Most kids with viral meningitis recover fully within a week or two with supportive care.

Bacterial meningitis is the one that keeps pediatricians up at night. It can progress from early symptoms to life-threatening illness in hours. The top bacterial culprits in children beyond the newborn period are Streptococcus pneumoniae (the pneumococcus) and Neisseria meningitidis (the meningococcus). Globally, pneumococcus accounted for about 17% and meningococcus about 14% of childhood meningitis deaths in 2021.¹ The trouble for clinicians is that in the early hours, viral and bacterial meningitis can look identical. One study found that doctors prescribed antibiotics to more than half of children who turned out to have viral meningitis, simply because telling the two apart at the bedside is unreliable.⁷ This is often the right call — better to treat and then step back than to wait and let a bacterial infection spiral.

How Vaccines Changed the Landscape

The dramatic decline in childhood meningitis over the past 30 years is largely a vaccine story. Three conjugate vaccines did most of the heavy lifting: the Haemophilus influenzae type b (Hib) vaccine, the pneumococcal conjugate vaccine (PCV), and the meningococcal conjugate vaccine. Before the Hib vaccine rolled out in the late 1980s and early 1990s, H. influenzae was a leading cause of bacterial meningitis in young children. Between 1990 and 2019, deaths from H. influenzae meningitis in children under five dropped by more than 75%.⁸

Pneumococcal conjugate vaccines had a similarly striking effect. In the United States, after the introduction of PCV7, pneumococcal meningitis incidence dropped by about 64% in children under two years old.⁹ The Dutch surveillance study found that conjugate vaccines reduced H. influenzae type b, meningococcal serogroup C, and several pneumococcal strains by 96% to 98%.³ Meningococcal conjugate vaccines showed incidence declines ranging from 77% to 100% across different age groups in the studies that have evaluated them.¹⁰

Vaccines have not, however, eliminated the problem. Coverage gaps remain a major issue in many countries. In settings where vaccines are not widely available or where hesitancy and logistical barriers limit uptake, bacterial meningitis rates remain high. A study from a tertiary center in Pakistan highlighted that unvaccinated children had higher incidence of bacterial meningitis and pointed to obstacles like vaccine hesitancy, poor storage, and administration by inadequately trained personnel.¹¹ Even in high-income countries, individual children who miss their scheduled doses remain vulnerable to the very bacteria that vaccines have pushed to the margins.

Serotype Replacement

One complication of vaccine success is that as the targeted bacterial strains disappear, non-vaccine strains can fill the gap. This phenomenon, called serotype replacement, has been documented with pneumococcal vaccines. After PCV7 was introduced, the prevalence of the seven vaccine-targeted pneumococcal serotypes dropped steeply, but non-vaccine serotypes increased and were nearly twice as likely to acquire multiple antibiotic resistance over time.¹² Newer, broader vaccines (PCV13, PCV15, PCV20) were developed partly in response to this shift. Global projections suggest that by 2035, Neisseria meningitidis may overtake pneumococcus as the dominant pathogen behind childhood meningitis, reflecting a shifting landscape that vaccine strategy will need to keep chasing.²

Environmental and Household Risk Factors

Beyond age and vaccination status, several environmental exposures meaningfully raise a child’s risk. A systematic review and meta-analysis of risk factors for invasive meningococcal disease in children and adolescents found that crowded living conditions more than doubled the odds (roughly two and a half times the risk), secondhand smoke exposure doubled the odds, and a recent respiratory tract infection tripled them.¹³ A separate meta-analysis of invasive meningococcal disease across all ages confirmed HIV-positive status, passive smoke exposure, and crowded living conditions as significant risk factors.¹⁴

One finding that surprises many parents is that day care attendance may actually be somewhat protective against meningococcal disease in young children. A study found that children in day care had a lower risk of meningococcal disease than those cared for at home, possibly because they spent less time in prolonged close contact with adults, who are the main asymptomatic carriers of Neisseria meningitidis. The number of adults in the household and household crowding were the independent risk factors that mattered more.¹⁵ This runs counter to the common assumption that group child care is always the riskier environment for infectious disease.

Adolescent-Specific Risks

Meningitis risk does not follow a simple downward curve from infancy through childhood. Teenagers and young adults face a second smaller peak, particularly for meningococcal disease. The behaviors and living arrangements that come with adolescence create new opportunities for the bacteria to spread. A matched cohort study of adolescents identified intimate kissing with multiple partners (about a fourfold increase in risk), being a university student (roughly threefold), having a recent illness (roughly threefold), and a history of preterm birth (roughly fourfold) as independent risk factors for meningococcal disease.¹⁶ Living in dormitories, attending bars and clubs, and exposure to tobacco smoke further increase meningococcal carriage rates among young people.¹⁷ This is why many countries recommend a meningococcal booster dose before college.

Anatomical and Surgical Vulnerabilities

Some children carry elevated meningitis risk because of structural issues in or around the skull. Children with cochlear implants, for example, have a well-documented higher risk of bacterial meningitis. An early study found that a particular implant design with a positioner carried about four and a half times the odds of postoperative meningitis, and the combination of an inner-ear malformation with a cerebrospinal fluid leak raised the odds further still.¹⁸ More recent data from a large French surveillance cohort found that about 4% of bacterial meningitis cases in children over three months were linked to known cerebrospinal fluid leakage, and in that group, pneumococcus dominated at nearly 79% of cases.¹⁹ Children with congenital skull base abnormalities or a history of head trauma that created a path between the sinuses and the brain’s protective membranes are also at increased risk. Doctors typically recommend additional pneumococcal and meningococcal vaccinations for these children.

When Diagnosis Is Delayed

Because early meningitis symptoms overlap with common childhood illnesses like ear infections, upper respiratory infections, and generic fevers, delays in diagnosis happen more often than most people realize. A retrospective study at hospitals in New York City found that diagnosis was delayed by more than eight hours in over a third of bacterial meningitis patients, and the most common initial misdiagnoses were febrile viral illnesses and ear infections.²⁰ A lack of continuity of care, where the child sees a different provider each visit, was flagged as a contributing factor in an older but still relevant review of delayed diagnoses.²¹

These delays are not just frustrating; they directly affect outcomes. Having symptoms for more than 48 hours before admission, presenting in a coma or with seizures, and showing signs of shock have all been identified as prognostic factors for death or severe complications in multiple studies.²² In a study from Guatemala, symptom duration beyond three days before treatment roughly quadrupled the odds of death or major disability.²³ The practical takeaway for parents is this: any infant or child with an unexplained high fever and lethargy, a bulging soft spot, irritability that worsens when held, or a rapidly deteriorating appearance needs emergency evaluation, not a next-day appointment.

Long-Term Consequences for Survivors

Surviving bacterial meningitis does not always mean recovering fully. Roughly one in five children who survive faces severe long-term effects, with the exact rate depending on the pathogen involved. Pneumococcal meningitis, tuberculosis meningitis, and Group B streptococcal meningitis tend to cause the highest rates of lasting damage.²⁴ A long-term follow-up study of 60 survivors found that about a third had neurological problems persisting well into the future, with speech and language difficulties being the most common, affecting roughly 17% of survivors. Hearing loss occurred in about 3%.²⁵

The ripple effects extend well beyond the child. A qualitative systematic review of meningitis survivors and their families documented depression, social isolation, career disruptions, and unresolved grief as common experiences. In both high-income and low-income countries, caregivers frequently had to leave their jobs to provide ongoing support for a child with meningitis-related disabilities. Children themselves faced neurodevelopmental delays, and the financial burden of specialist visits, rehabilitation, and inpatient care accumulated over years or decades.²⁶ Much of this long-term cost, including out-of-pocket expenses and lost income, is poorly captured in published research.²⁷

Tuberculous Meningitis

In countries where tuberculosis is common, TB meningitis is a distinct and devastating threat to children. A modeling study estimated that about 24,000 children under 15 developed tuberculous meningitis globally in 2019, and roughly 16,100 of them died, the vast majority younger than five.²⁸ Among the roughly 7,900 who survived, more than 5,500 were estimated to have lasting neurological damage. TB meningitis is also associated with very high rates of stroke in children: one prospective study found signs of brain infarction on imaging in more than half of pediatric TB meningitis patients, and those with stroke had significantly worse outcomes.²⁹ TB meningitis rarely features in meningitis discussions aimed at parents in high-income countries, but for families in TB-endemic regions, it is one of the most lethal forms of the disease.

Immune Deficiencies That Fly Under the Radar

When a child develops severe bacterial meningitis without an obvious explanation, some clinicians investigate for underlying immune system problems. A population-based study in western France that tested children after serious bacterial infections found that about 12% had a definite or possible primary immune deficiency, most commonly involving the complement system, which is part of the body’s early defense against bacteria like meningococcus. Children with complement deficiencies are especially vulnerable to Neisseria meningitidis and can develop recurrent episodes of meningococcal disease. A child who has had meningitis more than once, or who develops meningococcal disease from an unusual serogroup, is often screened for these conditions. Identifying an immune deficiency changes management: these children may need additional vaccines, prophylactic antibiotics, or lifelong monitoring.